Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 02, 2024 09:00 ET | Source: EVERZOM

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields The...
March 05, 2024 03:10 ET | Source: Everzom

Licence exclusive avec Erganeo pour EVerGel, premier candidat médicament d’EVerZom, un traitement révolutionnaire des fistules et de la fibrose du tube digestif.

Licence exclusive avec Erganeo pour EVerGel, premier candidat médicament d’EVerZom, un traitement révolutionnaire des fistules et de la fibrose du tube digestif. Cette nouvelle licence mondiale est...
March 05, 2024 03:10 ET | Source: Everzom

Exclusive license agreement secured with Erganeo for EVerGel, EVerZom's first drug candidate, a breakthrough treatment for fistulas and fibrosis of the digestive tract.

Exclusive license agreement secured with Erganeo for EVerGel, EVerZom's first drug candidate, a breakthrough treatment for fistulas and fibrosis of the digestive tract. This new worldwide license...
December 13, 2023 05:07 ET | Source: Everzom

EVerZom : Ambition thérapeutique dans les biothérapies à base d’exosomes

EVerZom : Ambition thérapeutique dans les biothérapies à base d’exosomes Lauréat de l’EIC Accelerator pour sa plateforme d’innovation technologique, EVerZom dévoile son pipeline propriétaire de...
December 13, 2023 05:07 ET | Source: Everzom

EVerZom: Therapeutic Ambition in Exosome Biotherapies

EVerZom: Therapeutic Ambition in Exosome Biotherapies EVerZom, winner of the EIC Accelerator for its breakthrough technology platform, presents its proprietary pipeline of exosome-based...